Neura Editor
Professor of Neurology
University of Maryland Medical Center
Baltimore, Maryland

“Although neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and ALS have very different clinical manifestations, I view them as members of a family of diseases driven by similar underlying mechanisms. I hope Neura will help neurologists and their patients deal with the rapidly growing body of information about these and related diseases and identify advances with meaningful clinical impact.”

Dr. Fishman is Professor of Neurology, Director of Neurology Research, and Director of the Alzheimer's Center at the University of Maryland School of Medicine in Baltimore. He holds adjunct appointments in Neuroscience and Pharmacology. He is Chief of Neurology Service for the Maryland VA Health Care System.

Dr. Fishman received his BA degree from Johns Hopkins, his doctorate in neurobiology from Yale University, and his medical degree from Johns Hopkins University School of Medicine. After an internship at Baltimore City Hospital, he was a resident in neurology and a fellow in neurology and cell biology at Columbia-Presbyterian Medical Center in New York.

His clinical and research interests include Alzheimer's disease, Parkinson's disease, ALS, and related neurodegenerative diseases, botulinum toxin treatment, experimental drug development, and deep brain stimulation for movement disorders. He also leads a basic research group investigating new molecular therapies for neurodegenerative diseases, including experimental neurotoxins, novel neuroprotectants, gene and stem cell based therapies, with funding from the VA, NIH, and private foundations, including the ALS Society, the Society for PSP, the Blepharospasm Research Foundation and the Maryland Stem Cell Initiative.

Dr. Fishman is a member of the American Academy of Neurology, the American Neurological Association, and the Society for Neuroscience. He has served on the Board of Directors of the Alzheimer's Association of Greater Maryland, and a past chair of the University of Maryland IRB. He is also the author of over 80 publications, including 12 book chapters and numerous articles in peer-reviewed journals.

He is a frequent speaker at both a local and national level on development of new therapeutics for neurodegenerative diseases, and issues of translating basic science advances into effective therapies.